Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Starpharma Holdings Limited (SPL)
  6. Company Announcements

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.110 0.005 (4.35%)

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$45 Commitments Test Entity - First Quarter Report 31 Oct 2005 11:59AM $0.590 $0.110 $0.125 fallen by 81.36%
$45 US Associate DNT Major Collaboration with NCL 11 Oct 2005 1:09PM $0.630 $0.110 $0.125 fallen by 82.54%
$45 Secures full ownership of core technology 11 Oct 2005 8:29AM $0.630 $0.110 $0.125 fallen by 82.54%
$45 VivaGel development accelerated with US$20m funding from NIH 3 Oct 2005 9:28AM $0.655 $0.110 $0.125 fallen by 83.21%
$45 Trading Halt 30 Sep 2005 9:52AM n/a $0.110 $0.125 n/a
$45 Response to market speculation 29 Sep 2005 12:58PM $0.585 $0.110 $0.125 fallen by 81.20%
$45 Response to ASX Query re Share Price 28 Sep 2005 9:14AM $0.585 $0.110 $0.125 fallen by 81.20%
$45 Preliminary Final Report & Commentary 6 Sep 2005 2:03PM $0.470 $0.110 $0.125 fallen by 76.60%
$45 Commitments Test Entity - Fourth Quarter Report 28 Jul 2005 4:12PM $0.535 $0.110 $0.125 fallen by 79.44%
$45 Starpharma investee company DNT-new low cost nanostructures 19 May 2005 11:02AM $0.550 $0.110 $0.125 fallen by 80%
$45 Investee Company Dimerix Bioscience offered Grant 11 May 2005 3:05PM $0.590 $0.110 $0.125 fallen by 81.36%
$45 To receive up to $5.6m grant for product development 1 Apr 2005 9:56AM $0.690 $0.110 $0.125 fallen by 84.06%
$45 Work with Anadis on Respiratory Protection/Biodefense App. 1 Feb 2005 10:09AM $0.870 $0.110 $0.125 fallen by 87.36%
$45 Reinstatement to Official Quotation 27 Jan 2005 9:11AM $0.870 $0.110 $0.125 fallen by 87.36%
$45 Suspension from Official Quotation 24 Jan 2005 9:46AM n/a $0.110 $0.125 n/a
$45 Trading Halt 20 Jan 2005 9:44AM n/a $0.110 $0.125 n/a
$45 Clinical study shows VivaGel is safe 16 Dec 2004 9:16AM $0.790 $0.110 $0.125 fallen by 86.08%
$45 Reports positive clinical results for VivaGel 17 Nov 2004 7:33PM $0.740 $0.110 $0.125 fallen by 85.14%
$45 Starpharma to lead US$5.4M NIH project for HIV prevention 30 Sep 2004 3:05PM $0.880 $0.110 $0.125 fallen by 87.50%
$45 VivaGel FDA Clearance for 3rd Stage dosing in Phase 1 trial 3 Aug 2004 10:30AM $0.870 $0.110 $0.125 fallen by 87.36%
$45 Granted Additional Nanotechnology Patent in USA 7 Jun 2004 2:04PM $0.760 $0.110 $0.125 fallen by 85.53%
$45 Phase 1 Clinical Study - advancing to second stage 27 Apr 2004 10:20AM $0.740 $0.110 $0.125 fallen by 85.14%
$45 Phase 1 Clinical Study - advancing to second stage 27 Apr 2004 10:20AM $0.740 $0.110 $0.125 fallen by 85.14%
$45 Institutional share placement 18 Mar 2004 9:27AM $0.930 $0.110 $0.125 fallen by 88.17%
$45 Trading Halt 17 Mar 2004 9:15AM n/a $0.110 $0.125 n/a

726 - 750 of 757 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.